These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33545365)

  • 1. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis.
    Zhao C; Zong Z; Zhu Q; Wang Y; Li X; Zhang C; Ma C; Xue Y
    Vascul Pharmacol; 2021 Jun; 138():106841. PubMed ID: 33545365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
    Luo L; Wang Y; Hu P; Wu J
    Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
    Wang K; Yang C; Shi J; Gao T
    Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 inhibits hypoxia/reoxygenation-induced human umbilical vein endothelial cell injury via targeting the microRNA-320a/RAC1 axis.
    Zhu R; Hu X; Xu W; Wu Z; Zhu Y; Ren Y; Cheng L
    Biol Chem; 2020 Feb; 401(3):349-360. PubMed ID: 31408432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS promotes the progression of sepsis by activation of lncRNA HULC/miR-204-5p/TRPM7 network in HUVECs.
    Chen X; Song D
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis.
    Li G; Zong W; Liu L; Wu J; Pang J
    Bioengineered; 2022 Feb; 13(2):2791-2802. PubMed ID: 35038974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 Promotes STAT3-Mediated Endothelial Inflammation by Counteracting the Function of miR-590.
    Zhou Q; Run Q; Li CY; Xiong XY; Wu XL
    Cytogenet Genome Res; 2020; 160(10):565-578. PubMed ID: 33022677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-coding RNA MALAT1 Alleviates the Elevated Intraocular Pressure (Eiop)-induced Glaucoma Progression via Sponging miR-149-5p.
    Wang L; Gong J; Wang J; Dan J; Wang P
    Curr Eye Res; 2021 Jun; 46(6):903-911. PubMed ID: 33108931
    [No Abstract]   [Full Text] [Related]  

  • 9. Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis.
    Wang H; Lin S; Yang Y; Zhao M; Li X; Zhang L
    Bioengineered; 2022 May; 13(5):13728-13738. PubMed ID: 35706417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA NEAT1 inhibits oxidative stress-induced vascular endothelial cell injury by activating the miR-181d-5p/CDKN3 axis.
    Zhang M; Wang X; Yao J; Qiu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3129-3137. PubMed ID: 31352814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MALAT1 affects intermittent hypoxia-induced endothelial injury by regulating miR-142-3p/HMGB1.
    Chen MX; Chen LD; Huang JC; Zeng AM; Huang JF; Lin QC
    Sleep Breath; 2022 Dec; 26(4):2015-2024. PubMed ID: 35006556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA MIR155HG Accelerates the Progression of Sepsis via Upregulating MEF2A by Sponging miR-194-5p.
    Zhang C; Li J; Li H; Wang G; Wang Q; Zhang X; Li B; Xu H
    DNA Cell Biol; 2021 Jun; 40(6):811-820. PubMed ID: 34030477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease: SOCS2-AS1/miR-324-5p/CUEDC2 axis regulates the progression of human umbilical vein endothelial cells.
    Zhao J; Chen D
    Pediatr Res; 2022 Aug; 92(2):388-395. PubMed ID: 32688371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
    Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-150 affects endoplasmic reticulum stress via MALAT1-miR-150 axis-mediated NF-κB pathway in LPS-challenged HUVECs and septic mice.
    Liu L; Yan LN; Sui Z
    Life Sci; 2021 Jan; 265():118744. PubMed ID: 33181172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis.
    Guo JT; Wang L; Yu HB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9633-9644. PubMed ID: 33015807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
    Liu N; Feng S; Li H; Chen X; Bai S; Liu Y
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.